Preoperative Grading of Presumptive Low-Grade Astrocytomas on MR Imaging: Diagnostic Value of Minimum Apparent Diffusion Coefficient

References

1. ↵
   Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475–87

   FREE Full Text
2. ↵
   Bulakbasi N, Guvenc I, Onguru O, et al. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004;28:735–46

   CrossRefPubMed
3. ↵
   Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44:656–66

   CrossRefPubMed
4. ↵
   Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006;241:839–46

   CrossRefPubMedWeb of Science
5. ↵
   Tervonen O, Forbes G, Scheithauer BW, et al. Diffuse fibrillary astrocytomas: correlation of MRI features with histopathologic parameters and tumor grade. Neuroradiology 1992;34:173–78

   CrossRefPubMed
6. Pierallini A, Bonamini M, Bozzao A., et al. Supratentorial diffuse astrocytic tumors: proposal of an MRI classification. Eur Radiol 1997;7:395–99

   CrossRefPubMed
7. ↵
   Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34:463–69

   CrossRefPubMedWeb of Science
8. ↵
   Okamoto K, Ito J, Takahashi N, et al. MRI of high-grade astrocytic tumors: early appearance and evolution. Neuroradiology 2002;44:395–402

   CrossRefPubMedWeb of Science
9. ↵
   Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081–88

   Abstract/FREE Full Text
10. ↵
    Rollin N, Guyotat J, Streichenberger N, et al. Clinical relevance of diffusion and perfusion magnetic imaging in assessing intra-axial brain tumors. Neuroradiology 2006;48:150–59

    CrossRefPubMed
11. ↵
    Maia AC, Malheiros SM, da Rocha AJ, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 2005;26:777–83

    Abstract/FREE Full Text
12. ↵
    Fan GG, Deng QL, Wu ZH, et al. Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumor grading? Br J Radiol 2006;79:652–58

    Abstract/FREE Full Text
13. ↵
    Yamasaki F, Kurisu K, Satoh K, et al. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005;235:985–91

    CrossRefPubMedWeb of Science
14. ↵
    Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53–60

    CrossRefPubMedWeb of Science
15. ↵
    Barker FG, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997;80:936–41

    CrossRefPubMed
16. ↵
    Scott JN, Brasher PM, Sevick RJ, et al. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002;59:947–49

    Abstract/FREE Full Text
17. ↵
    Ginsberg LE, Fuller GN, Hashmi M, et al. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998;49:436–40

    CrossRefPubMedWeb of Science
18. ↵
    Mcknight TR, Lamborn KR, Love TD, et al. Correlation of magnetic resonance spectroscopic and growth characteristics within grades II and III gliomas. J Neurosurg 2007;106:660–66

    CrossRefPubMedWeb of Science
19. ↵
    Kitis O, Altay H, Calli C, et al. Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 2005;55:393–400

    CrossRefPubMed
20. ↵
    Bulakbasi N, Kocaoglu M, Ors F, et al. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003;23:225–33
21. ↵
    Lam WW, Poon WS, Metreweli C. Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol 2002;57:219–25

    CrossRefPubMed
22. ↵
    Murakami R, Sugahara T, Nakamura H. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007;243:493–99

    CrossRefPubMedWeb of Science
23. ↵
    Oh J, Henry RG, Pirzkall A, et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 2004;19:546–54

    CrossRefPubMed
24. ↵
    Maia AC, Malheiros SM, da Rocha AJ, et al. Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. J Neurosurg 2004;101:970–76

    PubMed
25. Hakyemez B, Erdogan C, Ercan I, et al. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005;60:493–502

    CrossRefPubMed
26. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98

    Abstract/FREE Full Text
27. ↵
    Sadeghi N, D'Haene N, Decaestecker C, et al. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476–82

    Abstract/FREE Full Text